Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2024 Europe Clinical Chemistry Analyzers and Reagents Market in 31 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review
US$ 27,500.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
June 2020
1440 pages
2024 Europe Clinical Chemistry and Immunodiagnostics Market in France, Germany, Italy, Spain, UK: Supplier Shares and Sales Segment Forecasts for Over 100 Tests, Competitive Landscape, Emerging technologies, Instrumentation Review
US$ 17,500.00
... including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by ... Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, ...
June 2020
900 pages
2024 Latin America Clinical Chemistry Analyzers and Reagents Market in 7 Countries: Emerging Opportunities, Supplier Strategies, Volume and Sales Forecasts for over 100 Tests, Technology and Instrumentation Review
US$ 8,750.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
June 2020
620 pages
2024 Middle East Clinical Chemistry Analyzers and Reagents Market in 11 Countries: Emerging Opportunities, Supplier Strategies, Volume and Sales Forecasts for Over 100 Tests, Technology and Instrumentation Review
US$ 9,500.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
June 2020
700 pages
2024 North America Clinical Chemistry Analyzers and Reagents Market in the USA, Canada, Mexico: Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review
US$ 9,500.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
June 2020
635 pages
